Rectus sheath catheters for postoperative analgesia following paediatric midline laparotomy
a randomised controlled trial
Chief Investigator
|
Institution
|
Dates
|
Funding Stream
|
Amount
|
| Dr Caroline Wilson |
University Hospitals Bristol and Weston NHS Foundation Trust
|
01/01/2025 to 31/12/2025
|
Bristol and Weston Hospitals Charity Spring 2024
|
£25,000.00 |
Summary
Abdominal surgery is one of the most common paediatric inpatient
operations. Often performed in the emergency setting, paediatric
laparotomy is an abdominal operation requiring a large, vertical
midline incision. It is crucial to managing life-threatening
intra-abdominal conditions including bowel obstruction, volvulus,
and infection. Given the nature of the incision, laparotomy is
known to cause severe post-operative pain and thus has a high
analgesic requirement.
Intravenous opioids via nurse or patient controlled analgesia
(NCA or PCA) pumps are commonly used to treat post-operative pain
following paediatric laparotomy. Although effective, systemic
opioids have a number of unwanted side effects, including nausea,
sedation and reduced bowel motility.
Rectus sheath catheters (RSCs) are a promising modality for
providing opioid-sparing pain relief following midline laparotomy.
Local anaesthetic, infused into the rectus sheath, provides sensory
blockade to the rectus abdominis and overlying skin. Despite
increasing popularity in adults, no clinical trials have been
conducted in the paediatric population, therefore evidence for RSC
use in children is scarce. Furthermore, there is no agreed
consensus on the most effective modality for post-operative
analgesia in paediatric midline laparotomy.
We aim to design a pragmatic randomised controlled trial (RCT)
to assess the clinical and cost effectiveness of RSCs in this
population. Our future NIHR HTA grant will be for a multicentre
placebo-controlled RCT comparing RSCs to standard opioid analgesia.
The population will be children (6 months - 16 years) undergoing
midline laparotomy. Our proposed primary outcomes are resting pain
scores and opioid consumption (via NCA/PCA) at 24 hours
post-operatively.